1. Evaluation on epithelial-mesenchymal state and microRNAs focusing on isolated alveolar epithelial cells from bleomycin injured rat lung.
- Author
-
Kawami M, Takenaka S, Kadekaru Y, Akai M, Konaka T, Yumoto R, and Takano M
- Subjects
- Alveolar Epithelial Cells cytology, Alveolar Epithelial Cells drug effects, Animals, Antibiotics, Antineoplastic administration & dosage, Antibiotics, Antineoplastic toxicity, Bleomycin administration & dosage, Lung Injury genetics, Lung Injury physiopathology, Male, MicroRNAs genetics, Pulmonary Fibrosis genetics, Pulmonary Fibrosis physiopathology, Rats, Rats, Sprague-Dawley, Time Factors, Bleomycin toxicity, Epithelial-Mesenchymal Transition drug effects, Lung Injury chemically induced, Pulmonary Fibrosis chemically induced
- Abstract
Several studies using bleomycin (BLM)-induced lung injury rat model revealed that epithelial-mesenchymal transition (EMT) contributes to pulmonary fibrosis. Conversely, microRNAs (miRNAs) are considered as useful markers of various diseases. In the present study, we aimed to characterize the EMT state through focusing on alveolar epithelial cells and identify the miRNAs that can be used as markers to predict pulmonary fibrosis using a BLM-induced lung injury rat model. Intratracheal administration of BLM increased hydroxyproline, a component of collagen, in lung tissues at day 14, but not at day 7. However, BLM induced EMT at day 7, which was accompanied with increased mRNA expression of α-smooth muscle actin, a representative EMT marker, in alveolar epithelium, thereby suggesting that EMT occurs prior to pulmonary fibrosis in alveolar epithelial cells. Using this rat model, the expression levels of several EMT-associated miRNAs were examined, and miR-222 was found to be upregulated in alveolar epithelial cells as well as bronchoalveolar lavage fluid from day 3. Our findings indicate that EMT in alveolar epithelial cells may occur before pulmonary fibrosis, and miR-222 may be used as a potential marker for early prediction of pulmonary fibrosis., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF